HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Hemodynamics and metabolic-energetic expenses of the influence of AR-L115 in patients with coronary artery disease (author's transl)].

Abstract
AR-L115 has been shown to substantially improve myocardial pump function in patients (pts) with advanced congestive cardiomyopathy by i.v. and by p.o.-route. Since AR-L115 effects on myocardial oxygen consumption (MVO2) and coronary blood flow (CSF) are unknown, the hemodynamic myocardial metabolic and ECG-responses to AR-L115 (2 mg/kg BW bolus) were monitored at the 9, 14 and 19-min interval in 7 patients coronary 3-vessel disease, exhibiting ischemia during pacing stress only. Maximal responses occurred at the 14th min after AR-L115. THere were (average) increases in cardiac index by 30%, in heart rate by 19%, in CSF by 39%, in MVO2 by 34%, and in dp/dt max by 27%. There were (average) decreases in peak systolic pressure by 13%, in PCW by 30%, in LVEDP by 42%, in systemic vascular resistance by 34%, and in coronary vascular resistance by 37%. All changes were significant (p less than 0.05). Unchanged (p greater than 0.05) remained myocardial lactate extraction, stroke work index, and stroke-index. The only moderate increase in MVO2 is possibly explained in that the increase in contractility was a least partially offset by the reductions in pre- and after load. The AR-L115-induced improved pump function was accompanied by moderate increases in MVO2 and CSF, but without evidence of myocardial ischemia.
AuthorsJ Thormann, W Kramer, M Schlepper
JournalZeitschrift fur Kardiologie (Z Kardiol) Vol. 70 Issue 5 Pg. 385-93 (May 1981) ISSN: 0300-5860 [Print] Germany
Vernacular TitleAR-L115-induzierte Anderungen der Hämodynamik, des koronaren Blutflusses und des Energiemetabolismus bei Patienten mit koronarer Herzerkrankung.
PMID7269726 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Imidazoles
  • Lactates
  • sulmazole
  • Oxygen
Topics
  • Cardiac Pacing, Artificial
  • Coronary Circulation (drug effects)
  • Coronary Disease (drug therapy)
  • Electrocardiography
  • Energy Metabolism (drug effects)
  • Hemodynamics (drug effects)
  • Humans
  • Imidazoles (therapeutic use)
  • Lactates (blood)
  • Male
  • Middle Aged
  • Myocardial Contraction (drug effects)
  • Oxygen (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: